Finding a new CEO is going to be difficult. There were over 100 biotechs that went public last year and are now hundreds of biotech with many looking for CEOs too. Biotech CEOs want to develop drugs, but CYDY job is going to to be heavily oriented toward fund raising. Right now they have no cash for funding trials so not a development will be secondary to funding for survival of the company. That is if they can find somebody real soon, as running out of cash looks pretty certain msometie in Q1'22.
Finding a new CEO is going to be difficult. There were over 100 biotechs that went public last year and are now hundreds of biotech with many looking for CEOs too. Biotech CEOs want to develop drugs, but CYDY job is going to be heavily fund raising oriented. Right now they have no cash for funding trials so development will be secondary to funding for survival of the company. That is if they can find somebody real soon, as running out of cash looks pretty likely sometime in Q1'22.